 | • レポートコード：MRC23Q35865 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の細胞ベースマルチプレックスアッセイ市場について調査・分析し、世界の細胞ベースマルチプレックスアッセイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他）、用途別セグメント分析（製薬＆バイオテクノロジー企業、病院＆研究所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、R&D Systems、Bio-Rad Laboratories、Protavio、Illumina、BD、Luminex Corporation、Agilent Technologies、Bio-Techne Corporation、Shimadzu Biotech、Abcam、Merck、Meso Scale Diagnostics、Promega Corporation、Siemens Healthineers、Boster Biological Technologyなどが含まれています。世界の細胞ベースマルチプレックスアッセイ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、細胞ベースマルチプレックスアッセイ市場規模を推定する際に考慮しました。本レポートは、細胞ベースマルチプレックスアッセイの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、細胞ベースマルチプレックスアッセイに関するビジネス上の意思決定に役立てることを目的としています。 ・細胞ベースマルチプレックスアッセイ市場の概要 - 細胞ベースマルチプレックスアッセイのタイプ別セグメント - 世界の細胞ベースマルチプレックスアッセイ市場規模：タイプ別分析（フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他） - 細胞ベースマルチプレックスアッセイの用途別セグメント - 世界の細胞ベースマルチプレックスアッセイ市場規模：用途別分析（製薬＆バイオテクノロジー企業、病院＆研究所、その他） - 世界の細胞ベースマルチプレックスアッセイ市場規模予測（2018年-2029年） ・細胞ベースマルチプレックスアッセイ市場の成長トレンド - 細胞ベースマルチプレックスアッセイの地域別市場規模（2018年-2029年） - 細胞ベースマルチプレックスアッセイ市場ダイナミクス - 細胞ベースマルチプレックスアッセイの業界動向 - 細胞ベースマルチプレックスアッセイ市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他 - 世界の細胞ベースマルチプレックスアッセイのタイプ別市場規模（2018年-2023年） - 世界の細胞ベースマルチプレックスアッセイのタイプ別市場規模（2024年-2029年） ・用途別セグメント：製薬＆バイオテクノロジー企業、病院＆研究所、その他 - 世界の細胞ベースマルチプレックスアッセイの用途別市場規模（2018年-2023年） - 世界の細胞ベースマルチプレックスアッセイの用途別市場規模（2024年-2029年） ・細胞ベースマルチプレックスアッセイの地域別市場規模 - 北米の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - アメリカの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - ヨーロッパの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - アジア太平洋の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - 中国の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - 日本の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - 韓国の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - インドの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - オーストラリアの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - 中南米の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） - 中東・アフリカの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、R&D Systems、Bio-Rad Laboratories、Protavio、Illumina、BD、Luminex Corporation、Agilent Technologies、Bio-Techne Corporation、Shimadzu Biotech、Abcam、Merck、Meso Scale Diagnostics、Promega Corporation、Siemens Healthineers、Boster Biological Technology ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Cell-Based Multiplex Assays market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cell-Based Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cell-Based Multiplex Assays include Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies and Bio-Techne Corporation, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Multiplex Assays.
The Cell-Based Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell-Based Multiplex Assays market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Based Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
R&D Systems
Bio-Rad Laboratories
Protavio
Illumina
BD
Luminex Corporation
Agilent Technologies
Bio-Techne Corporation
Shimadzu Biotech
Abcam
Merck
Meso Scale Diagnostics
Promega Corporation
Siemens Healthineers
Boster Biological Technology
Segment by Type
Flow Cytometry
Fluorescence Detection
Multiplex Real-Time PCR
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Based Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Based Multiplex Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry
1.2.3 Fluorescence Detection
1.2.4 Multiplex Real-Time PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cell-Based Multiplex Assays Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Based Multiplex Assays Market Perspective (2018-2029)
2.2 Cell-Based Multiplex Assays Growth Trends by Region
2.2.1 Global Cell-Based Multiplex Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell-Based Multiplex Assays Historic Market Size by Region (2018-2023)
2.2.3 Cell-Based Multiplex Assays Forecasted Market Size by Region (2024-2029)
2.3 Cell-Based Multiplex Assays Market Dynamics
2.3.1 Cell-Based Multiplex Assays Industry Trends
2.3.2 Cell-Based Multiplex Assays Market Drivers
2.3.3 Cell-Based Multiplex Assays Market Challenges
2.3.4 Cell-Based Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Based Multiplex Assays Players by Revenue
3.1.1 Global Top Cell-Based Multiplex Assays Players by Revenue (2018-2023)
3.1.2 Global Cell-Based Multiplex Assays Revenue Market Share by Players (2018-2023)
3.2 Global Cell-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Based Multiplex Assays Revenue
3.4 Global Cell-Based Multiplex Assays Market Concentration Ratio
3.4.1 Global Cell-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Multiplex Assays Revenue in 2022
3.5 Cell-Based Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Cell-Based Multiplex Assays Product Solution and Service
3.7 Date of Enter into Cell-Based Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Multiplex Assays Breakdown Data by Type
4.1 Global Cell-Based Multiplex Assays Historic Market Size by Type (2018-2023)
4.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2024-2029)
5 Cell-Based Multiplex Assays Breakdown Data by Application
5.1 Global Cell-Based Multiplex Assays Historic Market Size by Application (2018-2023)
5.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell-Based Multiplex Assays Market Size (2018-2029)
6.2 North America Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell-Based Multiplex Assays Market Size by Country (2018-2023)
6.4 North America Cell-Based Multiplex Assays Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Based Multiplex Assays Market Size (2018-2029)
7.2 Europe Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell-Based Multiplex Assays Market Size by Country (2018-2023)
7.4 Europe Cell-Based Multiplex Assays Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Based Multiplex Assays Market Size (2018-2029)
8.2 Asia-Pacific Cell-Based Multiplex Assays Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Based Multiplex Assays Market Size (2018-2029)
9.2 Latin America Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell-Based Multiplex Assays Market Size by Country (2018-2023)
9.4 Latin America Cell-Based Multiplex Assays Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Based Multiplex Assays Market Size (2018-2029)
10.2 Middle East & Africa Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell-Based Multiplex Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Detail
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Cell-Based Multiplex Assays Introduction
11.2.4 R&D Systems Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.2.5 R&D Systems Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Cell-Based Multiplex Assays Introduction
11.3.4 Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Protavio
11.4.1 Protavio Company Detail
11.4.2 Protavio Business Overview
11.4.3 Protavio Cell-Based Multiplex Assays Introduction
11.4.4 Protavio Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.4.5 Protavio Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Cell-Based Multiplex Assays Introduction
11.5.4 Illumina Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Cell-Based Multiplex Assays Introduction
11.6.4 BD Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.6.5 BD Recent Development
11.7 Luminex Corporation
11.7.1 Luminex Corporation Company Detail
11.7.2 Luminex Corporation Business Overview
11.7.3 Luminex Corporation Cell-Based Multiplex Assays Introduction
11.7.4 Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.7.5 Luminex Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cell-Based Multiplex Assays Introduction
11.8.4 Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Bio-Techne Corporation
11.9.1 Bio-Techne Corporation Company Detail
11.9.2 Bio-Techne Corporation Business Overview
11.9.3 Bio-Techne Corporation Cell-Based Multiplex Assays Introduction
11.9.4 Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.9.5 Bio-Techne Corporation Recent Development
11.10 Shimadzu Biotech
11.10.1 Shimadzu Biotech Company Detail
11.10.2 Shimadzu Biotech Business Overview
11.10.3 Shimadzu Biotech Cell-Based Multiplex Assays Introduction
11.10.4 Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.10.5 Shimadzu Biotech Recent Development
11.11 Abcam
11.11.1 Abcam Company Detail
11.11.2 Abcam Business Overview
11.11.3 Abcam Cell-Based Multiplex Assays Introduction
11.11.4 Abcam Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.11.5 Abcam Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Cell-Based Multiplex Assays Introduction
11.12.4 Merck Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.12.5 Merck Recent Development
11.13 Meso Scale Diagnostics
11.13.1 Meso Scale Diagnostics Company Detail
11.13.2 Meso Scale Diagnostics Business Overview
11.13.3 Meso Scale Diagnostics Cell-Based Multiplex Assays Introduction
11.13.4 Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.13.5 Meso Scale Diagnostics Recent Development
11.14 Promega Corporation
11.14.1 Promega Corporation Company Detail
11.14.2 Promega Corporation Business Overview
11.14.3 Promega Corporation Cell-Based Multiplex Assays Introduction
11.14.4 Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.14.5 Promega Corporation Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Detail
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Cell-Based Multiplex Assays Introduction
11.15.4 Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.15.5 Siemens Healthineers Recent Development
11.16 Boster Biological Technology
11.16.1 Boster Biological Technology Company Detail
11.16.2 Boster Biological Technology Business Overview
11.16.3 Boster Biological Technology Cell-Based Multiplex Assays Introduction
11.16.4 Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.16.5 Boster Biological Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details